LEADS BIOLABS-B to Join Hang Seng Composite Index and Become Eligible for Southbound Trading

Deep News
03/08

LEADS BIOLABS-B (09887) announced that, effective March 9, 2026, the company's shares will be included as a constituent of the Hang Seng Composite Index by Hang Seng Indexes Company Limited and will be added to the list of stocks eligible for the Southbound Stock Connect scheme.

The inclusion in the Hang Seng Composite Index and the Southbound Trading eligibility list represents significant recognition from the capital markets regarding the company's performance and value. This inclusion will permit qualified mainland Chinese investors to directly invest in the company's shares listed on The Stock Exchange of Hong Kong Limited through the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect mechanisms. The move is anticipated to substantially broaden the company's investor base, enhance the trading liquidity of its shares, and further optimize its shareholder structure.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10